CareDx, Inc. (CDNA) is a publicly traded Healthcare sector company. As of September 11, 2026, CDNA trades at $50.31 with a market cap of $2.59B and a P/E ratio of 23.31. CDNA moved +0.28% today. Year to date, CDNA is +161.34%; over the trailing twelve months it is +275.24%. Its 52-week range spans $10.96 to $53.67. Analyst consensus is buy with an average price target of $51.20. Rallies surfaces CDNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CareDx, Inc. (CDNA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CDNA moved +0.28% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $50.31 |
| Market Cap | $2.59B |
| P/E Ratio | 23.31 |
| EPS | $2.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $53.67 |
| 52-Week Low | $10.96 |
| Volume | 530.91K |
| Avg Volume | 0 |
| Revenue (TTM) | $458.09M |
| Net Income | $111.01M |
| Gross Margin | 0.00% |
6 analysts cover CDNA: 0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $51.20.